BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22858929)

  • 1. The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin.
    Webb SL; Sanders AJ; Mason MD; Jiang WG
    Oncol Rep; 2012 Oct; 28(4):1491-7. PubMed ID: 22858929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
    Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
    J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo.
    Sanders AJ; Parr C; Davies G; Martin TA; Lane J; Mason MD; Jiang WG
    J Exp Ther Oncol; 2006; 6(1):39-48. PubMed ID: 17228523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
    Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
    Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
    Förbs D; Thiel S; Stella MC; Stürzebecher A; Schweinitz A; Steinmetzer T; Stürzebecher J; Uhland K
    Int J Oncol; 2005 Oct; 27(4):1061-70. PubMed ID: 16142324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
    Davies G; Ablin RJ; Mason MD; Jiang WG
    J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.
    Owen KA; Qiu D; Alves J; Schumacher AM; Kilpatrick LM; Li J; Harris JL; Ellis V
    Biochem J; 2010 Feb; 426(2):219-28. PubMed ID: 20015050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis.
    Tsui KH; Chang PL; Feng TH; Chung LC; Sung HC; Juang HH
    Anticancer Res; 2008; 28(4A):1993-9. PubMed ID: 18649738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo.
    Webb SL; Sanders AJ; Mason MD; Jiang WG
    Mol Cell Biochem; 2013 Mar; 375(1-2):207-17. PubMed ID: 23238872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
    Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface.
    Stirnberg M; Maurer E; Horstmeyer A; Kolp S; Frank S; Bald T; Arenz K; Janzer A; Prager K; Wunderlich P; Walter J; Gütschow M
    Biochem J; 2010 Aug; 430(1):87-95. PubMed ID: 20518742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
    Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells.
    Davies G; Watkins G; Mason MD; Jiang WG
    Prostate; 2004 Sep; 60(4):317-24. PubMed ID: 15264243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.
    Baba T; Kawaguchi M; Fukushima T; Sato Y; Orikawa H; Yorita K; Tanaka H; Lin CY; Sakoda S; Kataoka H
    J Pathol; 2012 Oct; 228(2):181-92. PubMed ID: 22262311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
    Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
    Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of matriptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells.
    Tsui KH; Chang PL; Feng TH; Chung LC; Hsu SY; Juang HH
    Anticancer Res; 2008; 28(4A):1977-83. PubMed ID: 18649735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From prediction to experimental validation: desmoglein 2 is a functionally relevant substrate of matriptase in epithelial cells and their reciprocal relationship is important for cell adhesion.
    Wadhawan V; Kolhe YA; Sangith N; Gautam AK; Venkatraman P
    Biochem J; 2012 Oct; 447(1):61-70. PubMed ID: 22783993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.
    Morton RA; Ewing CM; Nagafuchi A; Tsukita S; Isaacs WB
    Cancer Res; 1993 Aug; 53(15):3585-90. PubMed ID: 8339265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.
    Liu JW; Shen JJ; Tanzillo-Swarts A; Bhatia B; Maldonado CM; Person MD; Lau SS; Tang DG
    Oncogene; 2003 Mar; 22(10):1475-85. PubMed ID: 12629510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.